Just when you thought cancer treatments had plateaued, ivermectin’s potential to inhibit the PAK1/Akt/mTOR pathway could revolutionize oncology; could this be the breakthrough we’ve been waiting for?
PAK1/Akt/mTOR Pathway Inhibition by Ivermectin in Cancer Models
